In an elderly patient with known heart failure presenting with palpitations and atrial fibrillation, without dyspnea, orthopnea, paroxysmal nocturnal dyspnea, or peripheral edema, what is the most appropriate initial treatment: propranolol, digoxin, furosemide, or dobutamine?

Digoxin is the Most Appropriate Initial Treatment

For an elderly patient with known heart failure presenting with atrial fibrillation and palpitations but without signs of acute decompensation (no dyspnea, orthopnea, PND, or edema), digoxin is the most appropriate initial treatment choice among the options provided.

Rationale for Digoxin

The ESC and AHA/ACC guidelines consistently support digoxin as a Class I recommendation for rate control in patients with heart failure and atrial fibrillation 1, 2, 3. Specifically:

• Digoxin is useful for initial control of ventricular rate in patients with rapid AF and may be considered in decompensated HF patients prior to initiation of a beta-blocker 1, 2
• In patients with symptomatic HF and AF, digoxin may be used to slow a rapid ventricular rate, particularly in those with LVEF <40% 1, 2
• Digoxin is especially appropriate in the acute setting for HF patients with AF when hemodynamic stability is a concern 3

Why Not the Other Options?

Propranolol (Beta-blocker)

While beta-blockers are preferred for long-term rate control, they have significant limitations in this acute presentation:

• Beta-blockers should be used with caution in patients with overt congestion, hypotension, or HF with reduced LVEF in the acute setting 3
• The patient's compensated status doesn't exclude underlying reduced ejection fraction
• In elderly patients, beta-blockers carry higher risk of hypotension and bradycardia 4

Furosemide

This is inappropriate because:

• The patient has NO signs of volume overload (no dyspnea, orthopnea, PND, or edema)
• Furosemide is indicated for fluid retention, not rate control 2
• Using diuretics without volume overload risks dehydration and electrolyte abnormalities, which can worsen digoxin toxicity 1

Dobutamine

This is contraindicated because:

• Dobutamine is a positive inotrope reserved for acute decompensated heart failure with hypotension or cardiogenic shock
• The patient is compensated without signs of low cardiac output
• Dobutamine would worsen tachycardia and increase myocardial oxygen demand

Practical Implementation

For this elderly patient, initiate digoxin with:

• Reduced dose of 0.125 mg or 0.0625 mg daily (elderly patients require lower doses due to reduced renal clearance) 1, 2
• No loading dose is needed in stable patients 1, 4
• Target serum concentration of 0.6-1.2 ng/mL 1
• Monitor electrolytes (especially potassium) and renal function, as hypokalaemia increases arrhythmia risk 1, 2

Important Caveats

Check for contraindications before administering digoxin 5:

• Second- or third-degree heart block without pacemaker
• Pre-excitation syndromes (WPW)
• Sick sinus syndrome

Long-term strategy: While digoxin is appropriate for initial rate control, beta-blockers (alone or combined with digoxin) are preferred for long-term management once the patient is stabilized 1, 2. The combination of digoxin and beta-blocker is superior to either agent alone for rate control at rest and during exercise 3, 4.

The key distinction here is that digoxin provides safe initial rate control in a compensated HF patient with new AF, avoiding the hemodynamic risks of beta-blockers in the acute setting while addressing the primary complaint of palpitations.